Journal of the science of food and agriculture · 2026
Cerasus humilis proanthocyanidins alleviate osteoporosis by regulating renal calcium metabolism.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Xinran, Shu Yanxia, Yu Chao, Feng Weiran, Li Hang, Li Weidong
Аннотация
BACKGROUND: Postmenopausal osteoporosis is associated with disturbed calcium homeostasis and renal calcium handling. Although Cerasus humilis proanthocyanidins (PA) show anti-osteoporotic activity, their effects on renal calcium metabolism remain unclear. We hypothesized that C. humilis PA could alleviate ovariectomy (OVX)-induced bone loss by improving renal calcium reabsorption.
RESULTS: Compared with untreated OVX rats, 12 weeks of PA treatment increased bone mineral density from 125.5 to 232.8 mg cm-3 and improved trabecular microarchitecture (P < 0.05). PA reduced β-C-terminal telopeptide and tartrate-resistant acid phosphatase-5b levels, increased bone-specific alkaline phosphatase levels, decreased 24 h urinary calcium excretion, and increased apparent calcium absorption from 50.4% to 87.8% (all P < 0.05). Renal histopathological alterations were attenuated, with increased renal bone morphogenetic protein-7 and urinary Klotho levels and decreased serum fibroblast growth factor 23 levels. Renal protein expression of transient receptor potential vanilloid 5 (TRPV5) and Calbindin-D28k increased by 53.0% and 45.6%, respectively (P < 0.05), with corresponding mRNA upregulation.
CONCLUSION: C. humilis PA alleviated OVX-induced bone loss and calcium metabolic disturbances. The effects were associated with reduced urinary calcium loss and increased renal TRPV5 and Calbindin-D28k expression. Renal calcium handling may therefore contribute to the anti-osteoporotic effect of C. humilis PA in OVX rats, and the potential as a dietary ingredient for bone health warrants further investigation. © 2026 Society of Chemical Industry.
RESULTS: Compared with untreated OVX rats, 12 weeks of PA treatment increased bone mineral density from 125.5 to 232.8 mg cm-3 and improved trabecular microarchitecture (P < 0.05). PA reduced β-C-terminal telopeptide and tartrate-resistant acid phosphatase-5b levels, increased bone-specific alkaline phosphatase levels, decreased 24 h urinary calcium excretion, and increased apparent calcium absorption from 50.4% to 87.8% (all P < 0.05). Renal histopathological alterations were attenuated, with increased renal bone morphogenetic protein-7 and urinary Klotho levels and decreased serum fibroblast growth factor 23 levels. Renal protein expression of transient receptor potential vanilloid 5 (TRPV5) and Calbindin-D28k increased by 53.0% and 45.6%, respectively (P < 0.05), with corresponding mRNA upregulation.
CONCLUSION: C. humilis PA alleviated OVX-induced bone loss and calcium metabolic disturbances. The effects were associated with reduced urinary calcium loss and increased renal TRPV5 and Calbindin-D28k expression. Renal calcium handling may therefore contribute to the anti-osteoporotic effect of C. humilis PA in OVX rats, and the potential as a dietary ingredient for bone health warrants further investigation. © 2026 Society of Chemical Industry.